“Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan”, JPEHSS, vol. 4, no. 1, pp. 129–136, Feb. 2026, doi: 10.63163/jpehss.v4i1.1040.